<VariationArchive VariationID="334367" VariationName="NM_000784.4(CYP27A1):c.526del (p.Asp176fs)" VariationType="Deletion" Accession="VCV000334367" Version="22" RecordType="classified" NumberOfSubmissions="10" NumberOfSubmitters="10" DateLastUpdated="2024-06-17" DateCreated="2013-10-01" MostRecentSubmission="2024-06-17">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="287615" VariationID="334367">
      <GeneList>
        <Gene Symbol="CYP27A1" FullName="cytochrome P450 family 27 subfamily A member 1" GeneID="1593" HGNC_ID="HGNC:2605" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>2q35</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="2" Accession="NC_000002.12" start="218782147" stop="218815293" display_start="218782147" display_stop="218815293" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="2" Accession="NC_000002.11" start="219646471" stop="219680015" display_start="219646471" display_stop="219680015" Strand="+" />
          </Location>
          <OMIM>606530</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_000784.4(CYP27A1):c.526del (p.Asp176fs)</Name>
      <CanonicalSPDI>NC_000002.12:218812299:GG:G</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>2q35</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="2" Accession="NC_000002.12" start="218812300" stop="218812300" display_start="218812300" display_stop="218812300" variantLength="1" positionVCF="218812299" referenceAlleleVCF="CG" alternateAlleleVCF="C" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="2" Accession="NC_000002.11" start="219677023" stop="219677023" display_start="219677023" display_stop="219677023" variantLength="1" positionVCF="219677022" referenceAlleleVCF="CG" alternateAlleleVCF="C" />
      </Location>
      <ProteinChange>D176fs</ProteinChange>
      <HGVSlist>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_007959.1" sequenceAccession="NG_007959" sequenceVersion="1" change="g.35553del">
            <Expression>NG_007959.1:g.35553del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000002.11" sequenceAccession="NC_000002" sequenceVersion="11" change="g.219677024del" Assembly="GRCh37">
            <Expression>NC_000002.11:g.219677024del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000002.12" sequenceAccession="NC_000002" sequenceVersion="12" change="g.218812301del" Assembly="GRCh38">
            <Expression>NC_000002.12:g.218812301del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000784.4" sequenceAccession="NM_000784" sequenceVersion="4" change="c.526del" MANESelect="true">
            <Expression>NM_000784.4:c.526del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000775.1" sequenceAccession="NP_000775" sequenceVersion="1" change="p.Asp176fs">
            <Expression>NP_000775.1:p.Asp176fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA2112637" DB="ClinGen" />
        <XRef ID="CYP27A1_00024" DB="LOVD 3" />
        <XRef Type="rs" ID="765512351" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000784.4(CYP27A1):c.526del (p.Asp176fs) AND Cholestanol storage disease" Accession="RCV000307005" Version="21">
        <ClassifiedConditionList TraitSetID="1177">
          <ClassifiedCondition DB="MedGen" ID="C0238052">Cholestanol storage disease</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
            <Description DateLastEvaluated="2024-03-29" SubmissionCount="9">Pathogenic/Likely pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000784.4(CYP27A1):c.526del (p.Asp176fs) AND CYP27A1-related disorder" Accession="RCV003422309" Version="4">
        <ClassifiedConditionList TraitSetID="89503">
          <ClassifiedCondition>CYP27A1-related disorder</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2022-09-22" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2024-03-29" NumberOfSubmissions="10" NumberOfSubmitters="10" DateCreated="2013-10-01" MostRecentSubmission="2024-06-17">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic/Likely pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">10775536</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">12555943</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">23287330</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">26937392</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">8931710</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">9392430</ID>
        </Citation>
        <Citation Type="review" Abbrev="GeneReviews">
          <ID Source="PubMed">20301583</ID>
          <ID Source="BookShelf">NBK1409</ID>
        </Citation>
        <DescriptionHistory Dated="2021-05-10">
          <Description>Likely pathogenic</Description>
        </DescriptionHistory>
        <DescriptionHistory Dated="2019-05-12">
          <Description>Likely pathogenic</Description>
        </DescriptionHistory>
        <DescriptionHistory Dated="2019-05-12">
          <Description>Pathogenic</Description>
        </DescriptionHistory>
        <ConditionList>
          <TraitSet ID="1177" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="873" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">CTX: Cerebrotendinous xanthomatosis</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Cholestanol storage disease</ElementValue>
                <XRef ID="63246000" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Cerebral cholesterinosis</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Cerebrotendinous Xanthomatosis</ElementValue>
                <XRef ID="NBK1409" DB="GeneReviews" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">CTX</ElementValue>
                <XRef Type="MIM" ID="213700" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="5622" />
                <XRef ID="5622" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Cerebrotendinous xanthomatosis (CTX) is a lipid storage disease characterized by infantile-onset diarrhea, childhood-onset cataract, adolescent- to young adult-onset tendon xanthomas, and adult-onset progressive neurologic dysfunction (dementia, psychiatric disturbances, pyramidal and/or cerebellar signs, dystonia, atypical parkinsonism, peripheral neuropathy, and seizures). Chronic diarrhea from infancy and/or neonatal cholestasis may be the earliest clinical manifestation. In approximately 75% of affected individuals, cataracts are the first finding, often appearing in the first decade of life. Xanthomas appear in the second or third decade; they occur on the Achilles tendon, the extensor tendons of the elbow and hand, the patellar tendon, and the neck tendons. Xanthomas have been reported in the lung, bones, and central nervous system. Some individuals show cognitive impairment from early infancy, whereas the majority have normal or only slightly impaired intellectual function until puberty; dementia with slow deterioration in intellectual abilities occurs in the third decade in more than 50% of individuals. Neuropsychiatric symptoms such as behavioral changes, hallucinations, agitation, aggression, depression, and suicide attempts may be prominent. Pyramidal signs (i.e., spasticity) and/or cerebellar signs almost invariably become evident between ages 20 and 30 years. The biochemical abnormalities that distinguish CTX from other conditions with xanthomas include high plasma and tissue cholestanol concentration, normal-to-low plasma cholesterol concentration, decreased chenodeoxycholic acid (CDCA), increased concentration of bile alcohols and their glyconjugates, and increased concentrations of cholestanol and apolipoprotein B in cerebrospinal fluid.</Attribute>
                <XRef ID="NBK1409" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301583</ID>
                <ID Source="BookShelf">NBK1409</ID>
              </Citation>
              <XRef ID="909" DB="Orphanet" />
              <XRef ID="C0238052" DB="MedGen" />
              <XRef ID="MONDO:0008948" DB="MONDO" />
              <XRef Type="MIM" ID="213700" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="89503" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="69773" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">CYP27A1-related condition</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">CYP27A1-related disorder</ElementValue>
              </Name>
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="145933" SubmissionDate="2013-04-30" DateLastUpdated="2013-10-01" DateCreated="2013-10-01">
        <ClinVarSubmissionID localKey="c.525-526delG_NBK1409" title="c.525-526delG and Cerebrotendinous Xanthomatosis" />
        <ClinVarAccession Accession="SCV000087197" DateUpdated="2013-10-01" DateCreated="2013-10-01" Type="SCV" Version="1" SubmitterName="GeneReviews" OrgID="500062" OrganizationCategory="resource" OrgAbbreviation="GeneReviews" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2013-08-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>pathologic</GermlineClassification>
          <Comment>Converted during submission to Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>not provided</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <Purpose>Assert pathogenicity</Purpose>
              <MethodType>curation</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="nucleotide change">c.525-526delG</Name>
          </OtherNameList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Cerebrotendinous Xanthomatosis</ElementValue>
            </Name>
            <XRef DB="GeneReviews" ID="NBK1409" />
            <XRef DB="OMIM" ID="213700" Type="MIM" />
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="740987" SubmissionDate="2019-02-01" DateLastUpdated="2019-05-24" DateCreated="2016-12-06">
        <ClinVarSubmissionID localKey="635306" localKeyIsSubmitted="1" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000427466" DateUpdated="2019-05-24" DateCreated="2016-12-06" Type="SCV" Version="3" SubmitterName="Illumina Laboratory Services, Illumina" OrgID="504895" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2017-04-27">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Likely pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">26937392</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">23287330</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">8931710</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">12555943</ID>
          </Citation>
          <Comment>The CYP27A1 c.525delG (p.Asp176MetfsTer6) variant, also known as c.526delG, results in a frameshift, and is predicted to result in premature termination of the protein. The p.Asp176MetfsTer6 variant has been reported in four studies in which it is found in a total of five individuals with cerebrotendinous xanthomatosis, including two siblings, all of whom were homozygous for the variant (Verrips et al. 1996; Clayton et al. 2002; Shah et al. 2012; Dutta et al. 2015). The variant has also been reported in a heterozygous state in one unaffected individual. Control data are unavailable for this variant which is reported at a frequency of 0.00012 in the South Asian population of the Exome Aggregation Consortium, but this is based on two alleles only in a region of good sequence coverage so the variant is presumed rare. Due to the potential impact of frameshift variants and the supporting evidence from the literature, the p.Asp176MetfsTer6 variant is classified as likely pathogenic for cerebrotendinous xanthomatosis. This variant was observed by ICSL as part of a predisposition screen in an ostensibly healthy population.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ICSL Variant Classification Criteria 09 May 2019</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/thsgk7t4/icsl_variant_classification_criteria_09_may_2019.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="CYP27A1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh37" Chr="2" alternateAllele="C" referenceAllele="CG" start="219677022" stop="219677023" variantLength="2" />
          </Location>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000784.3:c.526delG</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="213700" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB5118208</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="2235231" SubmissionDate="2019-08-05" DateLastUpdated="2019-12-23" DateCreated="2019-12-23">
        <ClinVarSubmissionID localKey="569343|OMIM:213700" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001132161" DateUpdated="2019-12-23" DateCreated="2019-12-23" Type="SCV" Version="1" SubmitterName="Counsyl" OrgID="320494" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2017-10-17">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">8931710</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">26937392</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">23287330</ID>
          </Citation>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="CYP27A1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh37" Chr="2" alternateAllele="C" referenceAllele="CG" start="219677022" stop="219677023" variantLength="2" />
          </Location>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="213700" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB6133108</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="4073884" SubmissionDate="2022-02-09" DateLastUpdated="2022-04-23" DateCreated="2022-04-23">
        <ClinVarSubmissionID localKey="NM_000784.4:c.526del|Cerebrotendinous xanthomatosis" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002078772" DateUpdated="2022-04-23" DateCreated="2022-04-23" Type="SCV" Version="1" SubmitterName="Natera, Inc." OrgID="500034" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2021-01-19">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000784.4:c.526del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Cerebrotendinous xanthomatosis</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB10993736</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="5449615" SubmissionDate="2022-12-13" DateLastUpdated="2022-12-31" DateCreated="2022-12-31">
        <ClinVarSubmissionID localKey="NM_000784.4:c.526del|OMIM:213700" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002801302" DateUpdated="2022-12-31" DateCreated="2022-12-31" Type="SCV" Version="1" SubmitterName="Fulgent Genetics, Fulgent Genetics" OrgID="500105" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-01-05">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000784.4:c.526del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="213700" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12390657</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="5507043" SubmissionDate="2023-01-09" DateLastUpdated="2023-01-21" DateCreated="2023-01-21">
        <ClinVarSubmissionID localKey="11200121478" localKeyIsSubmitted="1" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002820230" DateUpdated="2023-01-21" DateCreated="2023-01-21" Type="SCV" Version="1" SubmitterName="Neuberg Centre For Genomic Medicine, NCGM" OrgID="508108" OrganizationCategory="laboratory" OrgAbbreviation="NCGM" />
        <RecordStatus>current</RecordStatus>
        <Classification>
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>This variant causes a frameshift starting with codon Aspartic Acid 176, changes this amino acid to Methionine residue, and creates a premature Stop codon at position 6 of the new reading frame, denoted p.Asp176MetfsTer6. This variant has been previously reported in affected patients and has segregated with disease (Dutta AK et al, Shah K et al, Clayton PT et al). The variant has been reported to ClinVar as Pathogenic. The p.Asp176MetfsTer6 variant is novel (not in any individuals) in 1000 Genomes and is present at a frequency of 0.00012 in South Asian population in the gnomad database. The variant is predicted to cause loss of function due to protein truncation. Loss of function variants have been previously reported to be disease causing. Hence the above variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
            <TraitSet Type="Finding">
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <XRef DB="HP" ID="HP:0001250" />
              </Trait>
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <XRef DB="HP" ID="HP:0002373" />
              </Trait>
            </TraitSet>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="CYP27A1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000784.4:c.526del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="213700" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12521961</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7697906" SubmissionDate="2023-10-19" DateLastUpdated="2023-11-20" DateCreated="2023-11-20">
        <ClinVarSubmissionID localKey="22072601|CYP27A1-related condition" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004117517" DateUpdated="2023-11-20" DateCreated="2023-11-20" Type="SCV" Version="1" SubmitterName="PreventionGenetics, part of Exact Sciences" OrgID="239772" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-09-22">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>The CYP27A1 c.526delG variant is predicted to result in a frameshift and premature protein termination (p.Asp176Metfs*6). This variant was reported in the homozygous state in individuals with cerebrotendinous xanthomatosis (reported as G deletion at position 546 or 547 in Verrips et al. 1996. PubMed ID: 8931710; Dutta et al. 2015. PubMed ID: 26937392). This variant is reported in 0.026% of alleles in individuals of South Asian descent in gnomAD (http://gnomad.broadinstitute.org/variant/2-219677022-CG-C). Frameshift variants in CYP27A1 are expected to be pathogenic. This variant is interpreted as pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="CYP27A1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000784.3:c.526delG</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">CYP27A1-related condition</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB13915440</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7129665" SubmissionDate="2024-01-26" DateLastUpdated="2024-02-04" DateCreated="2023-03-04">
        <ClinVarSubmissionID localKey="465964c7e72f17a35ad9162b75eed5b85331af085f3e8176d7093fcb77514120|OMIM:213700" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV003819406" DateUpdated="2024-02-04" DateCreated="2023-03-04" Type="SCV" Version="2" SubmitterName="Revvity Omics, Revvity" OrgID="167595" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-03-21">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000784.4:c.526del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="213700" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12922107</SubmissionName>
          <SubmissionName>SUB14173319</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="3112125" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-14" DateCreated="2021-05-10">
        <ClinVarSubmissionID localKey="4838487|MedGen:C0238052" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001586476" DateUpdated="2024-02-14" DateCreated="2021-05-10" Type="SCV" Version="4" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-05-19">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">9392430</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">10775536</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">26937392</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">8931710</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">26937392</ID>
          </Citation>
          <Comment>This sequence change creates a premature translational stop signal (p.Asp176Metfs*6) in the CYP27A1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in CYP27A1 are known to be pathogenic (PMID: 9392430, 10775536, 26937392). For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 334367). This variant is also known as c.546del. This premature translational stop signal has been observed in individuals with cerebrotendinous xanthomatosis (PMID: 8931710, 26937392). This variant is present in population databases (rs765512351, gnomAD 0.03%).</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="CYP27A1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000002.11:g.219677023del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0238052" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11431369</SubmissionName>
          <SubmissionName>SUB12508014</SubmissionName>
          <SubmissionName>SUB14200283</SubmissionName>
          <SubmissionName>SUB8755776</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7846030" SubmissionDate="2024-06-05" DateLastUpdated="2024-06-17" DateCreated="2023-12-30">
        <ClinVarSubmissionID localKey="NM_000784.4:c.526del|OMIM:213700" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004192641" DateUpdated="2024-06-17" DateCreated="2023-12-30" Type="SCV" Version="2" SubmitterName="Baylor Genetics" OrgID="1006" OrganizationCategory="laboratory" OrgAbbreviation="BCM: BMGL" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2024-03-29">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000784.4:c.526del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="213700" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>GA_HC_20231102_20240331</SubmissionName>
          <SubmissionName>SUB13856327</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="740987" TraitType="Disease" MappingType="XRef" MappingValue="213700" MappingRef="OMIM">
        <MedGen CUI="C0238052" Name="Cholestanol storage disease" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7846030" TraitType="Disease" MappingType="XRef" MappingValue="213700" MappingRef="OMIM">
        <MedGen CUI="C0238052" Name="Cholestanol storage disease" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="145933" TraitType="Disease" MappingType="Name" MappingValue="Cerebrotendinous Xanthomatosis" MappingRef="Preferred">
        <MedGen CUI="C0238052" Name="Cholestanol storage disease" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5449615" TraitType="Disease" MappingType="XRef" MappingValue="213700" MappingRef="OMIM">
        <MedGen CUI="C0238052" Name="Cholestanol storage disease" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2235231" TraitType="Disease" MappingType="XRef" MappingValue="213700" MappingRef="OMIM">
        <MedGen CUI="C0238052" Name="Cholestanol storage disease" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3112125" TraitType="Disease" MappingType="XRef" MappingValue="C0238052" MappingRef="MedGen">
        <MedGen CUI="C0238052" Name="Cholestanol storage disease" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="4073884" TraitType="Disease" MappingType="Name" MappingValue="Cerebrotendinous xanthomatosis" MappingRef="Preferred">
        <MedGen CUI="C0238052" Name="Cholestanol storage disease" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7129665" TraitType="Disease" MappingType="XRef" MappingValue="213700" MappingRef="OMIM">
        <MedGen CUI="C0238052" Name="Cholestanol storage disease" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5507043" TraitType="Finding" MappingType="XRef" MappingValue="HP:0001250" MappingRef="HP">
        <MedGen CUI="C0036572" Name="Seizure" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7697906" TraitType="Disease" MappingType="Name" MappingValue="CYP27A1-related condition" MappingRef="Preferred">
        <MedGen CUI="None" Name="CYP27A1-related disorder" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5507043" TraitType="Disease" MappingType="XRef" MappingValue="213700" MappingRef="OMIM">
        <MedGen CUI="C0238052" Name="Cholestanol storage disease" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5507043" TraitType="Finding" MappingType="XRef" MappingValue="HP:0002373" MappingRef="HP">
        <MedGen CUI="C0009952" Name="Febrile seizure (within the age range of 3 months to 6 years)" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

